Professor Halidou Tinto Pharm D by background, worked from 1995 to 1999 as Research Associate at Centre Muraz, Burkina Faso where he was involved in the epidemiological surveillance of malaria drug resistance. From 1999 to 2000, he worked at the Royal Danish School of Pharmacy, Denmark as Research Fellow in the development of alternative medicine against malaria. From 2001, he was recruited to be a research associate at the Institute for Health Research (IRSS) and seconded at Centre Muraz. From 2003 to 2006, he worked as PhD fellow in Medical Sciences at the Institute of Tropical Medicine in Antwerp, Belgium, where he studied the epidemiology of malaria drug resistance in Burkina Faso and the mechanism of resistance in Rwanda.
After obtaining his PhD in 2006, he returned to Burkina Faso where in 2008 he created a Clinical Research Unit. The unit has successfully conducted several trials including a malaria Phase III vaccine trial (RTS, S) and employs approximately 200 collaborators working on several research projects. He served as Scientific Director of Centre Muraz from 2013 to 2014 and recently as Regional Director of the IRSS in the Centre-West Region of Burkina Faso. In July 2016, he graduated as Professor of Parasitology at the Polytechnic University of Bobo-Dioulasso, Burkina Faso. He is the author and co-author of 93 publications in international peer-reviewed journals.